SCHEMBL12269677

SCHEMBL12269677

Cn1cncc1C#Cc1n[nH]c2cc(C(=O)NCc3ccccn3)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ GAA P10253 2/20 0.48
▸ POLB P06746 2/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ GLA P06280 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ITK Q08881 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ MAPK10 P53779 1/20 0.45
▸ DRD2 P14416 1/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ ROCK2 O75116 1/20 0.42
▸ ROCK1 Q13464 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ ITGB3 P05106 1/20 0.41
▸ ITGAV P06756 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12269971 0.85 HPGD (0.45) KDM4EALDH1A1GAAPOLBNPC1
SCHEMBL12269755 0.83 ITK (0.51) KDM4EALDH1A1GAAGLAITK
SCHEMBL12269795 0.83 ATM (0.49) KDM4EALDH1A1POLBRAB9ANPC1
SCHEMBL12317932 0.82 ITK (0.53) KDM4EALDH1A1GAAPOLBRAB9A
SCHEMBL12269662 0.79 TDP1 (0.38) KDM4EALDH1A1GAAITKHSD17B10
SCHEMBL12269661 0.78 MAP2K4 (0.42) KDM4EALDH1A1GAAPOLBRAB9A
SCHEMBL12269788 0.77 GSK3B (0.45) KDM4EPOLBHSD17B10MEN1KMT2A
SCHEMBL12269784 0.73 AKT1 (0.40) MAPK1
SCHEMBL12269673 0.72 ROCK2 (0.39) ALDH1A1GAAROCK2ROCK1LMNA
SCHEMBL12269735 0.72 TDP1 (0.46) KDM4EALDH1A1GAAITKMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212961-A1 Pyrazole Derivatives as Kinase Inhibitors BURNHAM INSTITUTE FOR MEDICAL RESEARCH 2011-09-01 — — US disclosed
US-7951832-B2 Pyrazole derivatives as kinase inhibitors BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-05-31 — — US disclosed
US-20090124621-A1 PYRAZOLE DERIVATIVES AS KINASE INHIBITORS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124621-A1 PYRAZOLE DERIVATIVES AS KINASE INHIBITORS BRAF, MAP3K1, MAP3K3 KDM4E 784/4885ALDH1A1 1648/4885GAA 2078/4885
US-20110212961-A1 Pyrazole Derivatives as Kinase Inhibitors BRAF, MAP3K1, MAP3K3 KDM4E 784/4885ALDH1A1 1648/4885GAA 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback